In conclusion, this study highlighted the potential of GAP-43 as a biomarker for pain severity and disease progression in degenerative spinal stenosis, while also emphasizing the influence of lifestyle factors such as smoking and alcohol consumption, as well as comorbid conditions such as diabetes. This evidence concerns the gene GAP43 and diabetes mellitus.